SEATTLE, WA, United States of America

Levi Todd

This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Levi Todd. Retrieved from https://idiyas.com/inventor/levi-todd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Levi Todd

Introduction

Levi Todd is an accomplished inventor based in Seattle, WA. She has made significant contributions to the field of biomedical research, particularly in the area of reprogramming Müller glia. Her work has the potential to advance treatments for various retinal diseases.

Latest Patents

Levi Todd holds a patent titled "Methods and Compositions for Reprogramming Müller Glia." This patent represents her innovative approach to utilizing Müller glia cells for therapeutic purposes. She has 1 patent to her name, showcasing her commitment to advancing scientific knowledge.

Career Highlights

Levi Todd is affiliated with the University of Washington, where she conducts her research. Her position at this prestigious institution allows her to collaborate with leading experts in her field and contribute to groundbreaking studies.

Collaborations

Some of her notable coworkers include Thomas A. Reh and Nikolas L. Jorstad. Their collaborative efforts enhance the research environment and foster innovation in their projects.

Conclusion

Levi Todd's work exemplifies the spirit of innovation in biomedical research. Her contributions are paving the way for future advancements in the treatment of retinal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…